Iris morphology.
Teus
Miguel A
MA
Arranz-Marquez
Esther
E
D000959:Antihypertensive Agents / Q000009:adverse effects*; D005127:Eye Color / Q000187:drug effects*; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D032801:Iridectomy; D007498:Iris / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D007499:Iris Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D000077338:Latanoprost; D008543:Melanins / Q000378:metabolism; D008544:Melanocytes / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D011461:Prostaglandins F, Synthetic / Q000009:adverse effects*
D000959:Antihypertensive Agents; D008543:Melanins; D011461:Prostaglandins F, Synthetic; D000077338:Latanoprost